Abstract:Objective To study the effects and mechanisms of myocardial injury in schistosome-infected mice.To investigate the effects and mechanisms of quercetin on myocardial injury due to the development of hepatic fibrosis after being treated by Praziquantel.Methods Eighty mice were divided into four groups:group A,group B,group C,and group D.Group A,group B,and group C were infected with Schistosoma japonicum cercariae.After 8 weeks,group A was treated with Praziquantel 500 mg/kg for 2d,group B was treated with quercetin 30mg/(kg·d) for 8 weeks after being treated with Praziquantel 500 mg/kg for 2 d.Group C was taken as experimental control without any treatment.Group D was taken as normal control.At the week 16,all mice were sacrificed and a part of liver tissue and myocardium tissue were preserved.HE Staining,electric microscope,RT-PCR,and immunohistochemical technique were applied to observing the changes of hepatic and cardiac histopathology,myocardial ultramicrostructure,the expression of myocardial c-los,c-jun Mrna,and the contents of myocardial transforming growth factorβ1 (TGF-β1),type Ⅰ and type Ⅲ collagen in mice infected with S.japonicum before and after treatments.Results There was different degree of myocardial injury among three groups of experimental control,Praziquantel treatment,Praziquantel combined with quercetin treatment.Praziquantel treatment relieved the degree of hepatic fibrosis and myocardial injury.The content of myocardial c-fos Mrna,c-jun Mrna,TGF-β1,type Ⅰ and type Ⅲ collagen were obviously reduced compared to the experimental control.When Praziquantel treatment combined with quercetin,the degree of hepatic fibrosis and myocardial injury were further relieved.Although the content of myocardial c-fos Mrna,c-jun Mrna,TGF-β1,type Ⅰ and thype Ⅲ collagen were still higher than those in normal control,those were reduced significantly compared to the group treated with Praziquantel.Conclusion Hepatic cirrhosis due to advanced schistosomiasis may lead to cardiac remodeling by stimulating the expression of immediate early gene and promoting the overexpression of TGF-β in myocardium.Anti-fibrosis therapy can reduce the degree of cardiac remodeling.Quercetin may protect myocardium through reducing,the degree of hepatic fibrosis and inhibiting the expression of immediate early gene,which could decrease the level of myocardial TGF-β1.

In vivo Therapeutic Effects and Mechanisms of Hydroxyasiaticoside Combined With Praziquantel in the Treatment of Schistosomiasis Induced Hepatic Fibrosis

The Role of Praziquantel in the Prevention and Treatment of Fibrosis Associated with Schistosomiasis: A Review.

Effect of Anluohuaxian Tablet Combined with Γ-Ifn on Schistosomal Liver Fibrosis

Investigation on the role of praziquantel against Schistosoma japonicum induced liver fibrosis and expression change of host miRNA

Effects of IL-18 on immunoregulation in mice infected with Schistosoma japonica following praziquantel treatment

'Silymarin' a Potential Treatment Targeting Hepatic Fibrosis of Schistosomiasis

Therapeutic potential of natural products in schistosomiasis-associated liver fibrosis

Praziquantel Ameliorates CCl4‐induced Liver Fibrosis in Mice by Inhibiting TGF‐β/Smad Signalling Via Up‐regulating Smad7 in Hepatic Stellate Cells

Effect of quercetin combined with Praziquantel on expression of myocardial immediate early gene and transforming growth factor-β1 in mice infected with Schistosomiasis japanica

Recombinant Sj16 Protein with Novel Activity Alleviates Hepatic Granulomatous Inflammation and Fibrosis Induced by Schistosoma Japonicum Associated with M2 Macrophages in a Mouse Model

Sorafenib and Praziquantel Synergistically Attenuate Schistosoma Japonicum-Induced Liver Fibrosis in Mice

The Intervention Effects and Mechanisms of KangXianLing PrescriptionⅠon Schistosomiasis Liver Fibrosis in Mice

Activation of Primary Hepatic Stellate Cells and Liver Fibrosis Induced by Targeting TGF-β1/Smad Signaling in Schistosomiasis in Mice

Changes of Ultrasonography and Two Serum Biochemical Indices for Hepatic Fibrosis in Schistosomiasis Japonica Patients One Year after Praziquantel Treatment

Preliminary Exploration on Anti-Fibrosis Effect of Kaempferol in Mice with Schistosoma Japonicum Infection

IFN‐γ Gene Therapy by Intrasplenic Hepatocyte Transplantation: a Novel Strategy for Reversing Hepatic Fibrosis in Schistosoma Japonicum‐infected Mice

The change of the hepatic fibrosis and pigment deposition in mice schistosomal liver fibrosis treated with combination of Anluohuaxian pilule and interferon-γ

Evaluation of the antiparasitic and antifibrotic effects of gallic acid on experimental hepatic schistosomiasis mansoni

Transdermal Praziquantel Administration Attenuates Hepatic Granulomatosis in Mice Infected with Schistosoma Japonicum

Effects of Sorafenib combined with Praziquantel on hepatic ifbrosis pathology of mice with schistosomiasis japonica

Intrasplenic Transplantation of IL-18 Gene-Modified Hepatocytes: an Effective Approach to Reverse Hepatic Fibrosis in Schistosomiasis Through Induction of Dominant Th1 Response